Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$74.52 - $117.06 $141,588 - $222,414
-1,900 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$99.52 - $215.83 $189,088 - $410,077
1,900 New
1,900 $290,000
Q3 2020

Oct 19, 2020

SELL
$89.56 - $126.72 $170,164 - $240,768
-1,900 Closed
0 $0
Q2 2020

Aug 03, 2020

SELL
$68.28 - $123.65 $136,560 - $247,300
-2,000 Reduced 51.28%
1,900 $213,000
Q3 2019

Oct 18, 2019

SELL
$86.25 - $120.16 $94,875 - $132,176
-1,100 Reduced 22.0%
3,900 $388,000
Q1 2019

May 01, 2019

BUY
$105.93 - $142.47 $529,650 - $712,350
5,000 New
5,000 $629,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.4B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Supplemental Annuity Collective Trust Of Nj Portfolio

Follow Supplemental Annuity Collective Trust Of Nj and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Supplemental Annuity Collective Trust Of Nj, based on Form 13F filings with the SEC.

News

Stay updated on Supplemental Annuity Collective Trust Of Nj with notifications on news.